Delivery Order SPE2DB22D1202-SPE2DB24FVNQ3

Award Date 9/13/24
Potential Completion Date 9/16/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,181.66, is for the supply of HAVRIX 720 unit/0.5 mL syringes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HAVRIX 1,440 unit/mL syringes. The contract has a ceiling value of $2,562.10 and an ultimate completion date of July 10, 2025. The award is not set aside and was issued under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HAVRIX 1,440 unit/mL syringes. The $38,134.58 firm fixed price contract has an ultimate completion date of August 1, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,013.47 firm fixed price delivery order is for the supply of HAVRIX 1,440 Unit/mL syringes. This order does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $3,023.02 award is for the supply of HAVRIX 1,440 unit/mL syringes. This delivery order falls under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a potential value of $999,999,999.00 and a performance period through...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the for-profit organization Amerisourcebergen Corporation. The contract has a potential value of $3,395.16 and a completion date of February 23, 2024. The contract is for the delivery of HAVRIX 720 unit/0.5 mL syringes. This award is part of a larger indefinite delivery contract (IDC) between DLA Troop Support Medical and...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a leading global pharmaceutical distribution company, for the supply of 1,440 unit/mL Havrix syringes. The order has a ceiling value of $1,905.50 and a completion date of April 12, 2024. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,110.37, is for the delivery of Havrix 1,440 unit/mL syringes. The ultimate completion date for this contract is August 2, 2024. This contract award is not associated with any set-aside program and is part of Amerisourcebergen's extensive portfolio of federal contracts, including an...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $36,674.00, is for the delivery of Havrix 1,440 unit/mL syringes. The contract has a firm fixed price and is set to complete by November 6, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Havrix 720 unit/0.5 mL syringes. The contract has a firm fixed price of $1,521.21 and a period of performance from May 15, 2024 to May 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVNQ3
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation for the supply of HAVRIX 1,440 unit/mL syringes. The delivery order, valued at $2,435.05, is a firm fixed-price contract with a completion date of September 16, 2024. This award appears to be part of a larger indefinite delivery contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract has no set-aside designation.

Generated 12/13/24, 9:38 AM